Huixia Cao
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
FGFR1/YAP1 signaling in endothelial cells drives renal fibrosis and offers a therapeutic target.
Journal: Frontiers in pharmacology
Published: December 26, 2025
Serum fibroblast growth factor 23 and kidney injury molecule-1 in the prediction of acute kidney injury in critically-ill patients.
Journal: Renal failure
Published: October 28, 2025
The associations between cardiometabolic index and mortalities in chronic kidney disease.
Journal: Medicine
Published: September 17, 2025
The correlation of neutrophil-percentage-to-albumin ratio with chronic kidney disease risk among the United States diabetic population.
Journal: Medicine
Published: June 25, 2025
The AMPK/ULK1/autophagy pathway: FGF23's weapon against GSDME-mediated pyroptosis in folic acid-induced acute kidney injury.
Journal: International immunopharmacology
Published: June 06, 2025
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study.
Journal: Frontiers in pharmacology
Published: June 06, 2025
Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC.
Journal: Frontiers in immunology
Published: April 21, 2025
Unveiling PANoptosis in Acute Kidney Injury: An Integrative Multi-Dimensional Approach to Identify Key Biomarkers.
Journal: Journal of inflammation research
Published: March 10, 2025
Identification of key genes in membranous nephropathy and non-alcoholic fatty liver disease by bioinformatics and machine learning.
Journal: Frontiers in immunology
Published: January 21, 2025
Erratum: Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells: Erratum.
Journal: Theranostics
Published: December 25, 2024
Last Updated: 09/26/2026